693. Clinical and Economic Outcomes Associated with Fidaxomicin in Comparison to Vancomycin, Metronidazole, and FMT: a Systematic Literature Review

por Li, Qinghua, Obi, Engels N, Marciniak, Anne, Newman, Rebecca
Publicado 2023

757. Evaluating Use of the New ICD-10 Codes for Clostridioides difficile Infection in the Premier U.S. Hospital Discharge Database

por Deshpande, Abhishek, Chen, Yiyun, Boye-Codjoe, Eugenia, Obi, Engels N
Publicado 2021

Correction to: Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States

por Jiang, Yiling, Sarpong, Eric M., Sears, Pamela, Obi, Engels N.
Publicado 2022

Adoption and Trends in Uptake of Updated ICD-10 Codes for Clostridioides difficile—A Retrospective Observational Study

por Deshpande, Abhishek, Chen, Yiyun, Boye-Codjoe, Eugenia, Obi, Engels N
Publicado 2022

The immunoglobulin tail tyrosine of membrane-bound IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched memory B cells

por Engels, N, König, L, Heemann, C, Tsubata, T, Griep, S, Schrader, V, Wienands, J
Publicado 2009

2814. The Impact of Novel Antibiotics on Curbing Antimicrobial Resistance and Infection Spread a Dynamic Modeling Study

por Ambavane, Apoorva, Litkiewicz, Michal, Sardesai, Aditya, Teloian, Diana, Obi, Engels N, Yang, Joe
Publicado 2023

Health Care Costs for Patients with Heart Failure Escalate Nearly 3-Fold in Final Months of Life

por Obi, Engels N., Swindle, Jason P., Turner, Stuart J., Russo, Patricia A., Altan, Aylin
Publicado 2016

678. Changes in the Clostridioides difficile Infection (CDI) Treatment Pattern Pre-Post Clinical Guideline Update in 2021 and Variations across Hospitals

por Dubberke, Erik R, Li, Qinghua, Obi, Engels N, Turzhitsky, Vladimir, Siddiqui, Fakhar, Nathanson, Brian H
Publicado 2023

762. Real-World Utilization of C. difficile Drug Treatments and Associated Clinical Outcomes in a US Hospital System

por McDaniel, Lauren, Everson, Nathan, White, Melissa, Obi, Engels N, Chen, Yiyun, Kohinke, Rose, Lockhart, Ellen Rachel
Publicado 2021

15. Real-World Changes in Clostridioides difficile infection (CDI) Treatment Utilization and Clinical Outcomes Associated with Updated 2017 IDSA Guidelines among Medicare Beneficia...

por Dubberke, Erik R, Puckett, Justin T, Obi, Engels N, Kamal-Bahl, Sachin, Desai, Kaushal, Stuart, Bruce, Doshi, Jalpa A
Publicado 2021

Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for Clostridioides difficile Infection and Associated Clinical Outcomes

por Dubberke, Erik R, Puckett, Justin T, Obi, Engels N, Kamal-Bahl, Sachin, Desai, Kaushal, Stuart, Bruce, Doshi, Jalpa A
Publicado 2022

Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital System

por McDaniel, Lauren F., White, Melissa N., Obi, Engels N., Kohinke, Rose M., Lockhart, Ellen Rachel S., Chipriano, Damian J., Chen, Yiyun, Everson, Nathan A.
Publicado 2022

Correction to: Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital System

por McDaniel, Lauren F., White, Melissa N., Obi, Engels N., Kohinke, Rose M., Lockhart, Ellen Rachel S., Chipriano, Damian J., Chen, Yiyun, Everson, Nathan A.
Publicado 2022

798. Metronidazole Exposure Prior to Clostridiodes difficile Infection (CDI) is a Risk Factor for Severe C. difficile Disease in Cancer Patients

por Francisco, Denise Marie A, Zhang, Liangliang, Jiang, Ying, Olvera, Adilene, Guevara, Eduardo Yepez, Garey, Kevin W, Peterson, Christine, Dillon, Ryan J, Obi, Engels N, Okhuysen, Pablo C
Publicado 2020

Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of life

por Hengel, Richard L., Schroeder, Claudia P., Jo, Jinhee, Ritter, Timothy E., Nathan, Ramesh V., Gonzales-Luna, Anne J., Obi, Engels N., Dillon, Ryan J., Van Anglen, Lucinda J., Garey, Kevin W.
Publicado 2022

787. Evaluation of Clostridioides difficile Environmental Contamination Surrounding C. difficile Patients vs. non-C. difficile Patients in Outpatient Infusion Centers

por Garey, Kevin W, Hengel, Richard L, Ritter, Timothy E, Nathan, Ramesh V, Nathan, Ramesh V, Schroeder, Claudia P, da Costa, Gabriela L Pedro, Lancaster, Christopher K, Obi, Engels N, Van Anglen, Lucinda J
Publicado 2020

Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer

por Francisco, Denise Marie A., Zhang, Liangliang, Jiang, Ying, Olvera, Adilene, Adachi, Javier, Guevara, Eduardo Yepez, Aitken, Samuel L., Garey, Kevin W., Peterson, Christine B., Do, Kim-Anh, Dillon, Ryan, Obi, Engels N., Jenq, Robert, Okhuysen, Pablo C.
Publicado 2022

Sacubitril/Valsartan Initiation Among Veterans Who Are Renin‐Angiotensin‐Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection Fraction

por Mohanty, April F., Levitan, Emily B., King, Jordan B., Dodson, John A., Vardeny, Orly, Cook, James, Herrick, Jennifer S., He, Tao, Patterson, Olga V., Alba, Patrick R., Russo, Patricia A., Obi, Engels N., Choi, Michelle E., Fang, James C., Bress, Adam P.
Publicado 2021

Development of a patient decision aid for discharge planning of hospitalized patients with stroke

por Prick, J. C. M., van Schaik, S. M., Deijle, I. A., Dahmen, R., Brouwers, P. J. A. M., Hilkens, P. H. E., Garvelink, M. M., Engels, N., Ankersmid, J. W., Keus, S. H. J., The, R., Takahashi, A., van Uden-Kraan, C. F., van der Wees, P. J., Van den Berg-Vos, R. M.
Publicado 2022